Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T60213 | Target Info | |||
Target Name | Bone morphogenetic protein receptor (BMPR2) | ||||
Synonyms | PPH1; Bone morphogenetic protein receptor type-2; Bone morphogenetic protein receptor type II; BMPR-II; BMPR-2; BMP type-2 receptor; BMP type II receptor | ||||
Target Type | Literature-reported Target | ||||
Gene Name | BMPR2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Growth factors | [+] 2 Growth factors | + | |||
Interacting Target Name | Bone morphogenetic protein 4 (BMP4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DVR4; Bone morphogenetic protein 2B; BMP-4; BMP-2B; BMP2B | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
3 | Reconstituted Complex | [3] | |||
Interacting Target Name | Bone morphogenetic protein 2 (BMP2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Bone morphogenetic protein 2A; BMP-2A; BMP2A; BMP-2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Reconstituted Complex | [5] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Activin receptor-like kinase 2 (ALK-2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSR-I; TGF-B superfamily receptor type I; SKR1; Serine/threonine-protein kinase receptor R1; ACVRLK2; ACTR-I; Activin receptor type-1; Activin receptor type I | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Yeast two hybrid | [4] | |||
4 | Yeast two hybrid | [7] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7632-6. | ||||
REF 2 | Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet. 2002 Jun 15;11(13):1517-25. | ||||
REF 3 | Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic. J Biol Chem. 2017 Mar 10;292(10):4138-4151. | ||||
REF 4 | Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol. 1995 Jul;15(7):3479-86. | ||||
REF 5 | BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 2000 Jul 3;19(13):3314-24. | ||||
REF 6 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 7 | Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. J Biol Chem. 1995 Mar 10;270(10):5625-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.